Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection

Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 194; no. 10; pp. 1208 - 1218
Main Authors Hinks, Timothy S. C., Wallington, Joshua C., Williams, Anthony P., Djukanović, Ratko, Staples, Karl J., Wilkinson, Tom M. A.
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 15.11.2016
Subjects
Online AccessGet full text
ISSN1073-449X
1535-4970
1535-4970
DOI10.1164/rccm.201601-0002OC

Cover

Loading…
Abstract Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells. To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD. Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi. Frequencies of Vα7.2 CD161 MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold. MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids.
AbstractList Rationale: Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells. Objectives: To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD. Methods: Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi. Measurements and Main Results: Frequencies of Vα7.2 + CD161 + MAIT cells, surface expression of the major histocompatibility complex–related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25–0.96) compared with healthy control subjects (1.8%; IQR, 1.4–2.5; P  = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2–2.3; P  = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46–1.3) compared with healthy control subjects (4.0%; IQR, 1.6–5.0; P  = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ–positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold. Conclusions: MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids.
Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells.RATIONALEMucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells.To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD.OBJECTIVESTo investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD.Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi.METHODSEleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi.Frequencies of Vα7.2+CD161+ MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold.MEASUREMENTS AND MAIN RESULTSFrequencies of Vα7.2+CD161+ MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold.MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids.CONCLUSIONSMAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids.
Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells. To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD. Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi. Frequencies of Vα7.2 CD161 MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold. MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids.
Author Staples, Karl J.
Wilkinson, Tom M. A.
Hinks, Timothy S. C.
Djukanović, Ratko
Williams, Anthony P.
Wallington, Joshua C.
Author_xml – sequence: 1
  givenname: Timothy S. C.
  surname: Hinks
  fullname: Hinks, Timothy S. C.
  organization: Clinical & Experimental Sciences and, Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, United Kingdom, Department for Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia; and
– sequence: 2
  givenname: Joshua C.
  surname: Wallington
  fullname: Wallington, Joshua C.
  organization: Clinical & Experimental Sciences and
– sequence: 3
  givenname: Anthony P.
  surname: Williams
  fullname: Williams, Anthony P.
  organization: Cancer Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Southampton, United Kingdom, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom
– sequence: 4
  givenname: Ratko
  surname: Djukanović
  fullname: Djukanović, Ratko
  organization: Clinical & Experimental Sciences and, Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, United Kingdom
– sequence: 5
  givenname: Karl J.
  orcidid: 0000-0003-3844-6457
  surname: Staples
  fullname: Staples, Karl J.
  organization: Clinical & Experimental Sciences and, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom
– sequence: 6
  givenname: Tom M. A.
  surname: Wilkinson
  fullname: Wilkinson, Tom M. A.
  organization: Clinical & Experimental Sciences and, Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, United Kingdom, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27115408$$D View this record in MEDLINE/PubMed
BookMark eNp9UsuO0zAUjdAg5gE_wAJZYsMmxddxE2eDhDrAVCoUiUFiZznOzdQjxy62U6n8Fj-IS2cQzIKNbcnncR_nvDhx3mFRPAc6A6j566D1OGMUagolpZStF4-KM5hX85K3DT3Jb9pUJeftt9PiPMZbSoEJoE-KU9YAzDkVZ8XPLwmDN31pXD9p7MklDkYbdHpP_EA-TtpHZUsVo9dGpQxYup0KRrlErskCrY3EOJI2SBab4J3RZN3FFCadzA7J58mO3qmwJ5cmoopIVpO7mZHluLVGq2S8i2TwgXzyLu23qDqL5Erh6LcbY6eD9mAndD8UZuMB9YHxtHg8KBvx2d19UXx9_-56cVWu1h-Wi7erUvOKphLamgH0AufYcCF4BcgqEIqptoIOK971nNd1q7FT-WxrpZVqdA8MWsFqUV0Ub46626kbsdfoUlBWboMZc0fSKyP__XFmI2_8Ts4BOOcsC7y6Ewj--4QxydFEnWemHPopSsg2dUOFOHi9fAC99VNwub2M4lCLvN8qo178XdGfUu73mQHiCNDBxxhwkNqk32POBRorgcpDdOQhOvIYHXmMTqayB9R79f-QfgF5xMvY
CitedBy_id crossref_primary_10_1038_s41385_020_0331_5
crossref_primary_10_1038_s41385_021_00469_5
crossref_primary_10_4168_aair_2024_16_6_585
crossref_primary_10_3389_fimmu_2020_01014
crossref_primary_10_1016_j_ejphar_2022_174821
crossref_primary_10_3389_fimmu_2022_1107609
crossref_primary_10_1513_AnnalsATS_201807_441OC
crossref_primary_10_1111_imm_12925
crossref_primary_10_1080_08820139_2023_2298398
crossref_primary_10_1186_s12931_021_01755_3
crossref_primary_10_4049_immunohorizons_2100003
crossref_primary_10_1016_j_molimm_2018_08_022
crossref_primary_10_3389_fimmu_2021_640455
crossref_primary_10_3389_fimmu_2022_819992
crossref_primary_10_1016_j_jaci_2021_07_037
crossref_primary_10_1183_13993003_00455_2022
crossref_primary_10_1111_imm_13653
crossref_primary_10_1016_j_jaci_2023_06_021
crossref_primary_10_1084_jem_20171739
crossref_primary_10_1183_13993003_01848_2017
crossref_primary_10_1007_s00281_019_00740_9
crossref_primary_10_1177_1753466621995050
crossref_primary_10_3390_life12030341
crossref_primary_10_1038_s41467_018_07207_9
crossref_primary_10_1007_s00011_019_01259_3
crossref_primary_10_1080_17476348_2022_2092099
crossref_primary_10_1016_j_cyto_2017_07_007
crossref_primary_10_1038_s41590_019_0444_8
crossref_primary_10_1164_rccm_201605_0942ED
crossref_primary_10_1165_rcmb_2022_0131OC
crossref_primary_10_3389_fimmu_2020_01845
crossref_primary_10_1002_JLB_4RI0118_023R
crossref_primary_10_1016_j_vaccine_2021_10_044
crossref_primary_10_1183_13993003_00037_2017
crossref_primary_10_1016_j_jaci_2017_08_009
crossref_primary_10_1038_s41577_020_00477_9
crossref_primary_10_3389_fimmu_2019_01597
crossref_primary_10_1002_cpim_89
crossref_primary_10_1016_j_ekir_2024_11_007
crossref_primary_10_3390_v13020241
crossref_primary_10_3389_fimmu_2022_981740
crossref_primary_10_3389_fimmu_2020_01691
crossref_primary_10_3390_biom13020213
crossref_primary_10_1016_j_molimm_2018_09_026
crossref_primary_10_3389_fimmu_2021_748741
crossref_primary_10_1002_cpim_90
crossref_primary_10_1038_s41577_019_0191_y
crossref_primary_10_1183_16000617_0008_2022
crossref_primary_10_3389_fimmu_2017_01837
crossref_primary_10_1016_j_imlet_2024_106910
crossref_primary_10_1111_cei_13377
crossref_primary_10_1016_j_chest_2018_01_020
crossref_primary_10_1038_s41572_021_00259_0
crossref_primary_10_1093_intimm_dxab109
crossref_primary_10_1183_16000617_0045_2017
crossref_primary_10_1016_j_alit_2023_07_006
crossref_primary_10_1186_s12931_017_0671_1
crossref_primary_10_3389_fimmu_2018_01602
crossref_primary_10_1128_microbiolspec_BAD_0005_2016
crossref_primary_10_1016_j_dci_2019_02_020
crossref_primary_10_3389_fimmu_2018_02530
crossref_primary_10_1016_j_celrep_2025_115275
crossref_primary_10_1016_j_intimp_2022_108606
crossref_primary_10_1186_s12950_024_00376_z
crossref_primary_10_1080_08830185_2017_1365145
crossref_primary_10_3389_fimmu_2020_584521
crossref_primary_10_1002_cdt3_71
crossref_primary_10_1016_j_coi_2017_04_002
crossref_primary_10_1007_s10875_019_00640_5
crossref_primary_10_3389_fimmu_2023_1127588
crossref_primary_10_1038_s41467_018_05202_8
crossref_primary_10_1146_annurev_immunol_080719_015428
crossref_primary_10_4049_jimmunol_1900774
crossref_primary_10_4049_jimmunol_1701512
crossref_primary_10_1183_16000617_0041_2021
crossref_primary_10_1186_s12931_022_02045_2
crossref_primary_10_1038_s41423_020_00568_6
crossref_primary_10_1159_000487057
crossref_primary_10_1165_rcmb_2017_0162OC
crossref_primary_10_3389_fimmu_2023_1264351
crossref_primary_10_1111_imr_13325
crossref_primary_10_1080_08830185_2017_1380199
crossref_primary_10_3389_falgy_2024_1439303
crossref_primary_10_1111_cei_13165
crossref_primary_10_1016_j_intimp_2021_107485
crossref_primary_10_1183_13993003_01582_2017
Cites_doi 10.3389/fcimb.2011.00001
10.1002/eji.1830240508
10.1056/NEJMoa063070
10.1183/09031936.02.00000102
10.1164/rccm.201501-0044ST
10.1164/rccm.201302-0341OC
10.1016/j.rmed.2011.07.020
10.1056/NEJMoa064691
10.1164/rccm.201108-1553OC
10.1016/S1473-3099(14)70734-0
10.1080/15412550903140881
10.1182/blood-2011-05-353789
10.1111/j.1469-0691.2011.03700.x
10.1016/j.jaci.2012.07.023
10.1016/j.jaci.2015.01.014
10.1038/nature01433
10.1046/j.1365-3083.1996.d01-73.x
10.1016/j.rmed.2008.04.019
10.1182/blood-2005-05-2118
10.1371/journal.pbio.1000054
10.1056/NEJMoa012561
10.1016/B978-0-12-374279-7.06018-5
10.1016/S0140-6736(15)60357-9
10.1186/1465-9921-11-67
10.1164/rccm.200801-136OC
10.1164/ajrccm.164.11.2104093
10.1164/ajrccm.157.3.9707010
10.1136/bmj.320.7245.1297
10.1111/cei.12277
10.1038/ni.1890
10.1371/journal.pone.0121527
10.1111/j.1365-2710.2008.00970.x
10.1136/thorax.57.9.759
10.1002/eji.201343509
10.1378/chest.09-2992
10.1164/rccm.200708-1234OC
10.1016/S0140-6736(14)62447-8
10.1182/blood-2012-09-456095
10.1182/blood-2010-07-298372
10.1111/sji.12193
10.1164/rccm.201409-1654PP
10.1016/j.exger.2013.11.003
10.1097/MIB.0000000000000397
10.1093/nar/28.1.27
10.1186/1756-0500-6-522
10.1007/s00134-013-3163-x
10.1164/ajrccm/142.4.863
10.1164/rccm.201504-0782OC
10.1128/JVI.02789-13
10.1007/s00251-012-0666-5
10.1183/09031936.03.00031803
10.1111/imm.12582
10.5588/ijtld.15.0353
10.3109/15412555.2015.1069806
10.1038/ncomms3142
10.1016/S2213-2600(15)00242-8
10.1182/blood-2010-08-303339
10.1084/jem.189.12.1907
10.1038/nature11605
10.1073/pnas.1302799110
ContentType Journal Article
Copyright Copyright American Thoracic Society Nov 15, 2016
Copyright © 2016 by the American Thoracic Society 2016
Copyright_xml – notice: Copyright American Thoracic Society Nov 15, 2016
– notice: Copyright © 2016 by the American Thoracic Society 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1164/rccm.201601-0002OC
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: Proquest Central Journals
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-4970
EndPage 1218
ExternalDocumentID PMC5114442
4255925271
27115408
10_1164_rccm_201601_0002OC
Genre Journal Article
General Information
GrantInformation_xml – fundername: Wellcome Trust
GroupedDBID ---
-~X
.55
0R~
23M
2WC
34G
39C
53G
5GY
5RE
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8FW
8R4
8R5
AAWTL
AAYXX
ABJNI
ABOCM
ABPMR
ABUWG
ACGFO
ACGFS
ADBBV
AENEX
AFCHL
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
BAWUL
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
E3Z
EBS
EJD
EMOBN
EX3
F5P
FRP
FYUFA
GX1
H13
HMCUK
HZ~
IH2
J5H
KQ8
L7B
M1P
M5~
NAPCQ
O9-
OBH
OFXIZ
OGEVE
OK1
OVD
OVIDX
P2P
PCD
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
RWL
SJN
TAE
TEORI
THO
TR2
UKHRP
W8F
WH7
WOQ
WOW
X7M
~02
3V.
CGR
CUY
CVF
ECM
EIF
NPM
RPM
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c430t-196211d8e5e7488431e2318a2a931be34bd44669ceba69c96acaa7cd121982683
IEDL.DBID BENPR
ISSN 1073-449X
1535-4970
IngestDate Thu Aug 21 13:35:37 EDT 2025
Thu Sep 04 18:24:35 EDT 2025
Fri Jul 25 04:30:35 EDT 2025
Wed Feb 19 02:43:35 EST 2025
Thu Apr 24 23:12:09 EDT 2025
Tue Jul 01 02:01:01 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords MAIT cell
NTHi
corticosteroids
COPD
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c430t-196211d8e5e7488431e2318a2a931be34bd44669ceba69c96acaa7cd121982683
Notes SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this article.
ORCID 0000-0003-3844-6457
OpenAccessLink http://doi.org/10.1164/rccm.201601-0002OC
PMID 27115408
PQID 1841680023
PQPubID 40575
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5114442
proquest_miscellaneous_1826670888
proquest_journals_1841680023
pubmed_primary_27115408
crossref_citationtrail_10_1164_rccm_201601_0002OC
crossref_primary_10_1164_rccm_201601_0002OC
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-11-15
2016-Nov-15
20161115
PublicationDateYYYYMMDD 2016-11-15
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle American journal of respiratory and critical care medicine
PublicationTitleAlternate Am J Respir Crit Care Med
PublicationYear 2016
Publisher American Thoracic Society
Publisher_xml – name: American Thoracic Society
References bib36
bib37
bib34
bib35
bib32
bib33
bib30
bib31
bib29
bib27
bib28
bib40
bib47
bib48
bib45
bib46
bib43
bib44
bib41
bib42
bib7
bib8
bib5
bib3
bib38
bib4
bib39
bib1
bib2
bib50
bib51
bib14
bib58
bib15
bib59
bib12
bib56
bib13
bib57
bib10
bib54
bib11
bib55
bib52
bib53
bib49
bib61
bib62
bib60
bib25
bib26
bib23
bib24
bib21
bib22
bib20
Otczyk DC (bib9) 2011; 6
bib18
bib19
bib16
bib17
King PT (bib6) 2015; 2015
24322275 - Intensive Care Med. 2014 Feb;40(2):192-201
25946569 - Inflamm Bowel Dis. 2015 Jul;21(7):1529-40
23051753 - Nature. 2012 Nov 29;491(7426):717-23
26552490 - COPD. 2016;13(2):196-202
9517616 - Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):950-6
21760721 - Int J Chron Obstruct Pulmon Dis. 2011;6:345-51
8633212 - Scand J Immunol. 1996 May;43(5):537-44
12361359 - Eur Respir J Suppl. 2002 Sep;37:1s-2s
19278296 - PLoS Biol. 2009 Mar 10;7(3):e54
24269212 - Exp Gerontol. 2014 Jan;49:47-54
20576732 - Chest. 2011 Mar;139(3):505-12
12181400 - N Engl J Med. 2002 Aug 15;347(7):465-71
17314337 - N Engl J Med. 2007 Feb 22;356(8):775-89
10592173 - Nucleic Acids Res. 2000 Jan 1;28(1):27-30
24321049 - BMC Res Notes. 2013 Dec 09;6:522
22070637 - Clin Microbiol Infect. 2012 Sep;18(9):918-23
18079493 - Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7
22919570 - Front Cell Infect Microbiol. 2011 Nov 18;1:1
25409118 - Am J Respir Crit Care Med. 2015 Jan 15;191(2):141-8
26688539 - Int J Tuberc Lung Dis. 2016 Jan;20(1):129-35
23898209 - Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28
24846411 - Scand J Immunol. 2014 Oct;80(4):271-5
26165134 - Lancet Respir Med. 2015 Sep;3(9):729-34
21084709 - Blood. 2011 Jan 27;117(4):1250-9
23229473 - Immunogenetics. 2013 Feb;65(2):115-24
23223428 - Blood. 2013 Jan 24;121(4):614-23
22447964 - Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55
23846752 - Nat Commun. 2013;4:2142
18614347 - Respir Med. 2008 Aug;102(8):1099-108
2221594 - Am Rev Respir Dis. 1990 Oct;142(4):863-71
16282346 - Blood. 2006 May 1;107(9):3575-83
19863361 - COPD. 2009 Oct;6(5):320-9
10377186 - J Exp Med. 1999 Jun 21;189(12):1907-21
26778581 - Immunology. 2016 May;148(1):1-12
10807619 - BMJ. 2000 May 13;320(7245):1297-303
22086415 - Blood. 2012 Jan 12;119(2):422-33
21119115 - Blood. 2011 Feb 3;117(5):1522-9
25012226 - Lancet Infect Dis. 2014 Dec;14(12):1281-92
26312864 - Lancet. 2015 Feb 26;385 Suppl 1:S42
19125898 - J Clin Pharm Ther. 2009 Feb;34(1):1-12
25775126 - PLoS One. 2015 Mar 16;10(3):e0121527
26114124 - J Immunol Res. 2015;2015:706376
26517304 - Am J Respir Crit Care Med. 2016 Mar 15;193(6):642-51
22033040 - Respir Med. 2012 Feb;106(2):257-68
8181517 - Eur J Immunol. 1994 May;24(5):1061-5
11739144 - Am J Respir Crit Care Med. 2001 Dec 1;164(11):2114-9
20513241 - Respir Res. 2010 May 31;11:67
25830527 - Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27
12762338 - Eur Respir J. 2003 Apr;21(4):574-81
22981793 - J Allergy Clin Immunol. 2012 Dec;130(6):1404-12.e7
27845580 - Am J Respir Crit Care Med. 2016 Nov 15;194(10 ):1177-1178
25746968 - J Allergy Clin Immunol. 2015 Aug;136(2):323-33
18787220 - Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81
24352438 - J Virol. 2014 Mar;88(5):2366-73
24019201 - Eur J Immunol. 2014 Jan;44(1):195-203
12200518 - Thorax. 2002 Sep;57(9):759-64
20581831 - Nat Immunol. 2010 Aug;11(8):701-8
24450998 - Clin Exp Immunol. 2014 May;176(2):266-74
23992479 - Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31
25608756 - Lancet. 2015 Apr 18;385(9977):1511-8
12634786 - Nature. 2003 Mar 13;422(6928):164-9
17409322 - N Engl J Med. 2007 Apr 5;356(14):1410-22
References_xml – ident: bib7
  doi: 10.3389/fcimb.2011.00001
– ident: bib56
  doi: 10.1002/eji.1830240508
– ident: bib13
  doi: 10.1056/NEJMoa063070
– ident: bib31
  doi: 10.1183/09031936.02.00000102
– ident: bib3
  doi: 10.1164/rccm.201501-0044ST
– ident: bib54
  doi: 10.1164/rccm.201302-0341OC
– ident: bib14
  doi: 10.1016/j.rmed.2011.07.020
– ident: bib33
  doi: 10.1056/NEJMoa064691
– ident: bib60
  doi: 10.1164/rccm.201108-1553OC
– ident: bib5
  doi: 10.1016/S1473-3099(14)70734-0
– volume: 2015
  start-page: 706376
  year: 2015
  ident: bib6
  publication-title: J Immunol Res
– ident: bib17
  doi: 10.1080/15412550903140881
– ident: bib35
  doi: 10.1182/blood-2011-05-353789
– ident: bib10
  doi: 10.1111/j.1469-0691.2011.03700.x
– ident: bib37
  doi: 10.1016/j.jaci.2012.07.023
– ident: bib20
  doi: 10.1016/j.jaci.2015.01.014
– ident: bib28
  doi: 10.1038/nature01433
– ident: bib59
  doi: 10.1046/j.1365-3083.1996.d01-73.x
– ident: bib16
  doi: 10.1016/j.rmed.2008.04.019
– ident: bib57
  doi: 10.1182/blood-2005-05-2118
– volume: 6
  start-page: 345
  year: 2011
  ident: bib9
  publication-title: Int J Chron Obstruct Pulmon Dis
– ident: bib24
  doi: 10.1371/journal.pbio.1000054
– ident: bib1
  doi: 10.1056/NEJMoa012561
– ident: bib29
  doi: 10.1016/B978-0-12-374279-7.06018-5
– ident: bib19
  doi: 10.1016/S0140-6736(15)60357-9
– ident: bib50
  doi: 10.1186/1465-9921-11-67
– ident: bib55
  doi: 10.1164/rccm.200801-136OC
– ident: bib8
  doi: 10.1164/ajrccm.164.11.2104093
– ident: bib49
  doi: 10.1164/ajrccm.157.3.9707010
– ident: bib12
  doi: 10.1136/bmj.320.7245.1297
– ident: bib46
  doi: 10.1111/cei.12277
– ident: bib34
  doi: 10.1038/ni.1890
– ident: bib36
  doi: 10.1371/journal.pone.0121527
– ident: bib44
  doi: 10.1111/j.1365-2710.2008.00970.x
– ident: bib51
  doi: 10.1136/thorax.57.9.759
– ident: bib39
  doi: 10.1002/eji.201343509
– ident: bib18
  doi: 10.1378/chest.09-2992
– ident: bib2
  doi: 10.1164/rccm.200708-1234OC
– ident: bib40
  doi: 10.1016/S0140-6736(14)62447-8
– ident: bib43
  doi: 10.1182/blood-2012-09-456095
– ident: bib53
  doi: 10.1182/blood-2010-07-298372
– ident: bib62
  doi: 10.1111/sji.12193
– ident: bib15
  doi: 10.1164/rccm.201409-1654PP
– ident: bib61
  doi: 10.1016/j.exger.2013.11.003
– ident: bib45
  doi: 10.1097/MIB.0000000000000397
– ident: bib30
  doi: 10.1093/nar/28.1.27
– ident: bib38
  doi: 10.1186/1756-0500-6-522
– ident: bib47
  doi: 10.1007/s00134-013-3163-x
– ident: bib32
  doi: 10.1164/ajrccm/142.4.863
– ident: bib52
  doi: 10.1164/rccm.201504-0782OC
– ident: bib48
  doi: 10.1128/JVI.02789-13
– ident: bib25
  doi: 10.1007/s00251-012-0666-5
– ident: bib58
  doi: 10.1183/09031936.03.00031803
– ident: bib21
  doi: 10.1111/imm.12582
– ident: bib11
  doi: 10.5588/ijtld.15.0353
– ident: bib41
  doi: 10.3109/15412555.2015.1069806
– ident: bib27
  doi: 10.1038/ncomms3142
– ident: bib4
  doi: 10.1016/S2213-2600(15)00242-8
– ident: bib23
  doi: 10.1182/blood-2010-08-303339
– ident: bib22
  doi: 10.1084/jem.189.12.1907
– ident: bib26
  doi: 10.1038/nature11605
– ident: bib42
  doi: 10.1073/pnas.1302799110
– reference: 24846411 - Scand J Immunol. 2014 Oct;80(4):271-5
– reference: 23898209 - Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28
– reference: 12181400 - N Engl J Med. 2002 Aug 15;347(7):465-71
– reference: 16282346 - Blood. 2006 May 1;107(9):3575-83
– reference: 23229473 - Immunogenetics. 2013 Feb;65(2):115-24
– reference: 11739144 - Am J Respir Crit Care Med. 2001 Dec 1;164(11):2114-9
– reference: 19863361 - COPD. 2009 Oct;6(5):320-9
– reference: 22981793 - J Allergy Clin Immunol. 2012 Dec;130(6):1404-12.e7
– reference: 8181517 - Eur J Immunol. 1994 May;24(5):1061-5
– reference: 23051753 - Nature. 2012 Nov 29;491(7426):717-23
– reference: 2221594 - Am Rev Respir Dis. 1990 Oct;142(4):863-71
– reference: 10807619 - BMJ. 2000 May 13;320(7245):1297-303
– reference: 19278296 - PLoS Biol. 2009 Mar 10;7(3):e54
– reference: 23992479 - Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31
– reference: 25608756 - Lancet. 2015 Apr 18;385(9977):1511-8
– reference: 24352438 - J Virol. 2014 Mar;88(5):2366-73
– reference: 25946569 - Inflamm Bowel Dis. 2015 Jul;21(7):1529-40
– reference: 20581831 - Nat Immunol. 2010 Aug;11(8):701-8
– reference: 22447964 - Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55
– reference: 26778581 - Immunology. 2016 May;148(1):1-12
– reference: 25746968 - J Allergy Clin Immunol. 2015 Aug;136(2):323-33
– reference: 22919570 - Front Cell Infect Microbiol. 2011 Nov 18;1:1
– reference: 23223428 - Blood. 2013 Jan 24;121(4):614-23
– reference: 18614347 - Respir Med. 2008 Aug;102(8):1099-108
– reference: 26688539 - Int J Tuberc Lung Dis. 2016 Jan;20(1):129-35
– reference: 26552490 - COPD. 2016;13(2):196-202
– reference: 18787220 - Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81
– reference: 26312864 - Lancet. 2015 Feb 26;385 Suppl 1:S42
– reference: 25775126 - PLoS One. 2015 Mar 16;10(3):e0121527
– reference: 10377186 - J Exp Med. 1999 Jun 21;189(12):1907-21
– reference: 27845580 - Am J Respir Crit Care Med. 2016 Nov 15;194(10 ):1177-1178
– reference: 22086415 - Blood. 2012 Jan 12;119(2):422-33
– reference: 12762338 - Eur Respir J. 2003 Apr;21(4):574-81
– reference: 21084709 - Blood. 2011 Jan 27;117(4):1250-9
– reference: 25409118 - Am J Respir Crit Care Med. 2015 Jan 15;191(2):141-8
– reference: 23846752 - Nat Commun. 2013;4:2142
– reference: 26165134 - Lancet Respir Med. 2015 Sep;3(9):729-34
– reference: 8633212 - Scand J Immunol. 1996 May;43(5):537-44
– reference: 26114124 - J Immunol Res. 2015;2015:706376
– reference: 25012226 - Lancet Infect Dis. 2014 Dec;14(12):1281-92
– reference: 12361359 - Eur Respir J Suppl. 2002 Sep;37:1s-2s
– reference: 21760721 - Int J Chron Obstruct Pulmon Dis. 2011;6:345-51
– reference: 17314337 - N Engl J Med. 2007 Feb 22;356(8):775-89
– reference: 24450998 - Clin Exp Immunol. 2014 May;176(2):266-74
– reference: 17409322 - N Engl J Med. 2007 Apr 5;356(14):1410-22
– reference: 24321049 - BMC Res Notes. 2013 Dec 09;6:522
– reference: 26517304 - Am J Respir Crit Care Med. 2016 Mar 15;193(6):642-51
– reference: 10592173 - Nucleic Acids Res. 2000 Jan 1;28(1):27-30
– reference: 24019201 - Eur J Immunol. 2014 Jan;44(1):195-203
– reference: 18079493 - Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7
– reference: 20576732 - Chest. 2011 Mar;139(3):505-12
– reference: 19125898 - J Clin Pharm Ther. 2009 Feb;34(1):1-12
– reference: 21119115 - Blood. 2011 Feb 3;117(5):1522-9
– reference: 22033040 - Respir Med. 2012 Feb;106(2):257-68
– reference: 12634786 - Nature. 2003 Mar 13;422(6928):164-9
– reference: 12200518 - Thorax. 2002 Sep;57(9):759-64
– reference: 20513241 - Respir Res. 2010 May 31;11:67
– reference: 25830527 - Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27
– reference: 24269212 - Exp Gerontol. 2014 Jan;49:47-54
– reference: 22070637 - Clin Microbiol Infect. 2012 Sep;18(9):918-23
– reference: 9517616 - Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):950-6
– reference: 24322275 - Intensive Care Med. 2014 Feb;40(2):192-201
SSID ssj0012810
Score 2.4957924
Snippet Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity....
Rationale: Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1208
SubjectTerms Adrenal Cortex Hormones - pharmacology
Adult
Aged
Female
Flow Cytometry
Haemophilus Infections - complications
Haemophilus Infections - immunology
Haemophilus influenzae - immunology
Humans
Male
Middle Aged
Mucosal-Associated Invariant T Cells - drug effects
Mucosal-Associated Invariant T Cells - immunology
Original
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - immunology
Young Adult
Title Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/27115408
https://www.proquest.com/docview/1841680023
https://www.proquest.com/docview/1826670888
https://pubmed.ncbi.nlm.nih.gov/PMC5114442
Volume 194
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZYJyFeEOO2wjYZiTcULRcnTnhB0G3qEO0m2KS-RY5zqlUKSVnXSfC3-IN8p3HDCtJe8uIT2_Gxj7-TcxPirQ9M78dTILfQjzzceIlnIIo9i7ux0D4ZozlQeDROhpfq8ySeuB9uC-dWuZaJK0FdNpb_kR8GbB9jdBN9mP_wuGoUW1ddCY0tsQ0RnMY9sf3peHz-tbMjhKnLR6AxEZVN1mEziTq8tpYj0YOE9Wn0ezbYvJr-w5v_uk3euYdOnojHDkDKjy3Hd8QDqp-KhyNnIn8mfn_DSjWz0oOyDbaV8og4SQRHWMpmKkfsoW4qzzi2gOC0voXCjBWWF3JAVbWQs1oCF0qXOFeeFS7L7C3J82WFlTDXP-VRa9qRXyAu3svTO57pEkBYjjnae04cmSWHhr4386tZteS-V1VRfhnCwK0jWP1cXJ4cXwyGnqvM4FkV-Tceji0UxzKlmDQkAEAIASemJjRZFBQUqaJkO3FmqTB4ZomxYLotA8hH6DNp9EL06qamXSFVotISZDosAhUDPoSUKVNk4dRkvqK0L4I1U3Lr0pZz9YwqX6kvicqZkXnLyLxlZF-8696Zt0k77qXeW_M6dwd4kf_dbn3xpmvG0WN7iqmpWTIN0I2GmMYkX7Zboxsu1JznyEeL3tg0HQGn9d5sqWdXq_TegMBKqfDV_dN6LR7xV3BYZBDviR72Ae0DH90UB2JLTzSe6SA4cAfiD2QdFFY
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VVgI2qLwDBQYJVsiqPR6_kKoKklYJTdIKUik7d2xP1EjGDk1TVD6KTX-Qc-OxaUDqrptsZmLP5L7OzX0x9s4Gpre9CZCbsF0LFs-3FFSxlcI2JoGtlQqoUHgw9LvH8svYG6-x33UtDKVV1jpxqaizMqX_yLcdio8RunF3Zz8smhpF0dV6hEbFFgf68idctvlOrwP6vhdif2_U7lpmqoCVStc-t8BycHqyUHs6APfCgGpgnFAJFblOol2ZZBTjjFKdKHxGvkpx4DRzINvA4qGL595hG4AZEaRo4_Pe8OhrE7cQoel_EODiMhrXZTq-3D5LU6p8d3zy33GPw_aqKfwP3_6bpnnN7u1vsgcGsPJPFYc9ZGu6eMTuDkxI_jG7-gbKlNPMgnMPNsl4R1NTCqro5OWEDygjXuWWMmyADb3iAg46KMpHvK3zfM6nBQcO5aZRLz9MTFfbC82PFjl-eXV2yTtVKIn3oZ4-8t61THgO4M2HVF0-01QJxrtKfy9np9N8Qc9eTmH5pTReXCWeFU_Y8a3Q7ClbL8pCP2dc-jLMsC0QiSM9wBWhI6mSSExUZEsdtphTEyVOTZt0mtaRx0t3yZcxETKuCBlXhGyxD813ZlWTkBt3b9W0jo3CmMd_2bvF3jbLEHWK36hClwvaAzQVwCzgkM8q1mheJwLqq2RjJVhhmmYDtRFfXSmmp8t24oDcUkrx4uZjvWH3uqNBP-73hgcv2X26EZVkOt4WWwdP6FfAZufJayMQnJ3ctgz-AcxATjs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VVKrYIN4ECgwSrJAVezx-ISEESaOENmkErZSdO7YnaiRjh6YpKr_Fjq_j3HhsGpC66yabmdhj39e5vi_GXtvA9LY3A3ITtmvB4vmWgiq2UtjGJLC1UgEVCo_G_uBYfp560y32u66FobTKWieuFXVWpvSNvONQfIzQjduZmbSISa__YfHdoglSFGmtx2lULLKvL3_AfVu-H_ZA6zdC9PeOugPLTBiwUuna5xbYDw5QFmpPB-BkGFMNvBMqoSLXSbQrk4zinVGqE4XfyFcpDp9mDuQcuDx0cd1bbDuAVQxbbPvT3njypYlhiND0QgjwEmQ0rUt2fNk5S1Oqgnd88uXxTIfdTbP4H9b9N2Xzig3s32V3DHjlHytuu8e2dHGf7YxMeP4B-_UVVCrnmQVHHyyT8Z6mBhVU3cnLGR9RdrzKLWVYAhuGxQWcdVCXH_GuzvMlnxccmJSbpr38MDEdbi80n6xyvHl1dsl7VViJH0BVvePDK1nxHCCcj6nSfKGpKowPlP5WLk7n-YquvZ7I8lNp3LhKQisesuMbodkj1irKQj9hXPoyzLAtEIkjPUAXoSOpkkjMVGRLHbaZUxMlTk3LdJrckcdr18mXMREyrggZV4Rss7fNfxZVw5Brd-_WtI6N8ljGf1m9zV41yxB7iuWoQpcr2gNkFcBE4JCPK9ZobicC6rFkYyXYYJpmA7UU31wp5qfr1uKA31JK8fT6Y71kO5C9-GA43n_GbtMDUXWm4-2yFlhCPwdMO09eGHng7OSmRfAPGHVSZw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Steroid-induced+Deficiency+of+Mucosal-associated+Invariant+T+Cells+in+the+Chronic+Obstructive+Pulmonary+Disease+Lung.+Implications+for+Nontypeable+Haemophilus+influenzae+Infection&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Hinks%2C+Timothy+S+C&rft.au=Wallington%2C+Joshua+C&rft.au=Williams%2C+Anthony+P&rft.au=Djukanovi%C4%87%2C+Ratko&rft.date=2016-11-15&rft.eissn=1535-4970&rft.volume=194&rft.issue=10&rft.spage=1208&rft_id=info:doi/10.1164%2Frccm.201601-0002OC&rft_id=info%3Apmid%2F27115408&rft.externalDocID=27115408
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon